Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Feline Breast Cancer Type 2 Susceptibility Protein Homolog (BRCA2)

Cat. No.AP2C229

Product TypeAnimal Proteins

Size

Product Overview

BioVenic's Recombinant Feline Breast Cancer Type 2 Susceptibility Protein Homolog (BRCA2) is a recombinant protein expressed from E.coli. Its predicted molecular weight is 377.4 kDa. The purity is>85% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Feline
Expression System E.coli
Purity >85% (SDS-PAGE)
Predicted Molecular Weight 377.4 kDa
Physical State Lyophilized
Formulation Tris/PBS-based buffer, 6% Trehalose.

Target Information

Feline breast cancer type 2 susceptibility protein homolog (BRCA2) is a key protein involved in maintaining genomic integrity by facilitating homologous recombination (HR) and repairing DNA double-strand breaks. In cats, BRCA2 functions similarly to its human counterpart, ensuring accurate DNA repair and preventing genomic instability. This protein is essential for safeguarding cells against mutations that can lead to cancer and other genetic disorders.

Protein Feline Breast Cancer Type 2 Susceptibility Protein Homolog (BRCA2)
Protein Synonym BRCA2; FANCD1Breast cancer type 2 susceptibility protein homolog; Fanconi anemia group D1 protein homolog
Gene ID 493878
UniProt ID Q864S8

Shipping and Storage

This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.
Inquiry Basket